SRC and ovarian cancer: In ovarian cancer, TRIM50 has been found to act as a negative regulator of Src protein, promoting ubiquitin-dependent K48-linked ubiquitination and the subsequent degradation of Src, thereby inhibiting ovarian cancer development 7.